4
Changes in Ownership
Mineralys Therapeutics, Inc. Filed Acc 0001933414-24-000046
Chief Medical Officer acquired 10,369 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rodman David Malcom Chief Medical Officer | 2024-10-11 | Option exercise | +5,017 | $0.54 | $2,709 | 130,622 | D |
| Rodman David Malcom Chief Medical Officer | 2024-10-14 | Option exercise | +5,352 | $1.08 | $5,780 | 135,974 | D |
| Derivatives | |||||||
| Rodman David Malcom Chief Medical Officer | 2024-10-11 | Option exercise · Stock Option | −5,017 | 15,052 | D | ||
| Rodman David Malcom Chief Medical Officer | 2024-10-14 | Option exercise · Stock Option | −5,352 | 165,434 | D | ||
Loading xslF345X05/wk-form4_1729023724.xml…